A noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysis
Abstract Objective Interstitial lung disease (ILD) is a common and serious complication of systemic sclerosis (SSc). It is usually classified by histologic type, but this classification may not fully reflect the clinical phenotypic variation. This study aimed to examine clinical features and aggrega...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-025-03722-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850128010220404736 |
|---|---|
| author | Yaqi Zhao Baoting Chao Wei Xu Xinya Li Jin Zhang Ying Zhang Zhenzhen Ma Qingrui Yang |
| author_facet | Yaqi Zhao Baoting Chao Wei Xu Xinya Li Jin Zhang Ying Zhang Zhenzhen Ma Qingrui Yang |
| author_sort | Yaqi Zhao |
| collection | DOAJ |
| description | Abstract Objective Interstitial lung disease (ILD) is a common and serious complication of systemic sclerosis (SSc). It is usually classified by histologic type, but this classification may not fully reflect the clinical phenotypic variation. This study aimed to examine clinical features and aggregate patients with SSc-ILD based on patients’ clinical manifestations, High-resolution computed tomography (HRCT) features and specific antibody expression to achieve precise treatment of SSc-ILD with early identification of complications. Methods This study included 103 patients with SSc-ILD. A cluster analysis was performed based on five clinical and serological variables to identify subgroups of patients. The survival rates between obtained clusters and risk factors affecting prognosis were also compared. Result Four clusters were identified in this study: Cluster 1 (n = 23) represented the lymphocytic interstitial pneumonia (LIP) group with LIP as the predominant HRCT characteristic. Cluster 2 (n = 23) was the worst prognosis group, with the highest Warrick score as well as the highest mortality rate. Cluster 3 (n = 20) with all patients having a negative anti-SCL-70 antibody response. Cluster 4 (n = 28) with all patients were positive for the anti-SCL-70 antibody. It was found that albumin was a protective factor for the prognosis of patients with SSC-ILD patients (p = 0.018), whereas age (p = 0.036) and IgM (p = 0.040) were risk factors. Conclusion The results of our cluster analysis indicated that based solely on histologic typing, may not be capturing the full heterogeneity of SSc-ILD patients. In order to identify homogeneous patient groups with a specific prognosis, HRCT features and antibody profiles should be taken into consideration. |
| format | Article |
| id | doaj-art-a5f217e7c7d848bba8a1c792e38741ad |
| institution | OA Journals |
| issn | 1471-2466 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pulmonary Medicine |
| spelling | doaj-art-a5f217e7c7d848bba8a1c792e38741ad2025-08-20T02:33:31ZengBMCBMC Pulmonary Medicine1471-24662025-05-0125111410.1186/s12890-025-03722-wA noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysisYaqi Zhao0Baoting Chao1Wei Xu2Xinya Li3Jin Zhang4Ying Zhang5Zhenzhen Ma6Qingrui Yang7Department of Rheumatology and Immunology, Cheeloo College of Medicine, Shandong Provincial Hospital, Shandong UniversityDepartment of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Rheumatology and Immunology, Cheeloo College of Medicine, Shandong Provincial Hospital, Shandong UniversityDepartment of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityThe First Clinical Medical College, Shandong University of Traditional Chinese MedicineDepartment of Rheumatology and Immunology, Cheeloo College of Medicine, Shandong Provincial Hospital, Shandong UniversityAbstract Objective Interstitial lung disease (ILD) is a common and serious complication of systemic sclerosis (SSc). It is usually classified by histologic type, but this classification may not fully reflect the clinical phenotypic variation. This study aimed to examine clinical features and aggregate patients with SSc-ILD based on patients’ clinical manifestations, High-resolution computed tomography (HRCT) features and specific antibody expression to achieve precise treatment of SSc-ILD with early identification of complications. Methods This study included 103 patients with SSc-ILD. A cluster analysis was performed based on five clinical and serological variables to identify subgroups of patients. The survival rates between obtained clusters and risk factors affecting prognosis were also compared. Result Four clusters were identified in this study: Cluster 1 (n = 23) represented the lymphocytic interstitial pneumonia (LIP) group with LIP as the predominant HRCT characteristic. Cluster 2 (n = 23) was the worst prognosis group, with the highest Warrick score as well as the highest mortality rate. Cluster 3 (n = 20) with all patients having a negative anti-SCL-70 antibody response. Cluster 4 (n = 28) with all patients were positive for the anti-SCL-70 antibody. It was found that albumin was a protective factor for the prognosis of patients with SSC-ILD patients (p = 0.018), whereas age (p = 0.036) and IgM (p = 0.040) were risk factors. Conclusion The results of our cluster analysis indicated that based solely on histologic typing, may not be capturing the full heterogeneity of SSc-ILD patients. In order to identify homogeneous patient groups with a specific prognosis, HRCT features and antibody profiles should be taken into consideration.https://doi.org/10.1186/s12890-025-03722-wSystemic sclerosisInterstitial lung diseaseCluster analysisHRCTWarrick score |
| spellingShingle | Yaqi Zhao Baoting Chao Wei Xu Xinya Li Jin Zhang Ying Zhang Zhenzhen Ma Qingrui Yang A noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysis BMC Pulmonary Medicine Systemic sclerosis Interstitial lung disease Cluster analysis HRCT Warrick score |
| title | A noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysis |
| title_full | A noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysis |
| title_fullStr | A noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysis |
| title_full_unstemmed | A noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysis |
| title_short | A noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysis |
| title_sort | noval identification of 4 systemic sclerosis interstitial lung disease subgroups using principal component analysis based cluster analysis |
| topic | Systemic sclerosis Interstitial lung disease Cluster analysis HRCT Warrick score |
| url | https://doi.org/10.1186/s12890-025-03722-w |
| work_keys_str_mv | AT yaqizhao anovalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT baotingchao anovalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT weixu anovalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT xinyali anovalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT jinzhang anovalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT yingzhang anovalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT zhenzhenma anovalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT qingruiyang anovalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT yaqizhao novalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT baotingchao novalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT weixu novalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT xinyali novalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT jinzhang novalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT yingzhang novalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT zhenzhenma novalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis AT qingruiyang novalidentificationof4systemicsclerosisinterstitiallungdiseasesubgroupsusingprincipalcomponentanalysisbasedclusteranalysis |